Literature DB >> 11891849

Phosphorylation of tyrosine 256 facilitates nuclear import of atypical protein kinase C.

Wendy O White1, M Lamar Seibenhener, Marie W Wooten.   

Abstract

Herein, we employed a combined approach of molecular modeling and site-directed mutagenesis to address the role of tyrosine phosphorylation in transport of atypical protein kinase C (aPKC) into the nucleus. Computer modeling of the three-dimensional structure of the aPKC catalytic core, reveals that tyrosine 256 (Tyr256) is located at the lip of the activation loop and is conserved among members of the aPKC family, iota/lambda and zeta. Based on these findings, we examined whether tyrosine phosphorylation of aPKC on the activation lip may facilitate nuclear import. An antiserum was generated that selectively recognizes the phosphorylated Tyr256 residue in aPKC. By isolating nuclei of PC12 cells and immunoprecipitating aPKC with Ab-PY256, we observed that Tyr256 is rapidly phosphorylated upon NGF treatment prior to entry of aPKC into the nucleus. aPKC was observed to exclusively bind to importin-beta. The interaction between importin-beta and aPKC was enhanced upon tyrosine phosphorylation of aPKC and binding was abrogated when Tyr256 was mutated to phenylalanine. We propose that phosphorylation of aPKC at Tyr256 induces a conformation, whereby, the arginine-rich NLS is exposed, which then binds importin-beta leading to import of aPKC into the nucleus. Altogether, these findings document a novel role for the tyrosine phosphorylation in regulating import of atypical PKC into the nucleus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891849

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

1.  Synaptic distributions of GluA2 and PKMζ in the monkey dentate gyrus and their relationships with aging and memory.

Authors:  Yuko Hara; Michael Punsoni; Frank Yuk; C Sehwan Park; William G M Janssen; Peter R Rapp; John H Morrison
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

2.  Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Authors:  Elena M Rodriguez; Elizabeth E Dunham; G Steven Martin
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 3.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 4.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

Review 5.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

6.  Tyrosine 132 phosphorylation of influenza A virus M1 protein is crucial for virus replication by controlling the nuclear import of M1.

Authors:  Shanshan Wang; Zhendong Zhao; Yuhai Bi; Lei Sun; Xiaoling Liu; Wenjun Liu
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

7.  Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.

Authors:  Wei Guo; Shuhong Wu; Jinsong Liu; Bingliang Fang
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 8.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

9.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

10.  Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signalling.

Authors:  Zezhou Wang; Shelley Sandiford; Chenggang Wu; Shawn Shun-Cheng Li
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.